Biodel To Present Results From VIAject(R) Phase 3 Studies At Advanced Technologies And Treatments For Diabetes Conference In Basel

Main Category: Diabetes
Also Included In: Clinical Trials / Drug Trials
Article Date: 12 Feb 2010 - 21:00 PDT

Current Article Ratings:

Patient / Public:
Healthcare Prof:

Biodel, Inc. (Nasdaq: BIOD) announced today that its chief executive officer, Dr. Sol Steiner, will present results from the company's two Phase 3 studies with VIAject® ultra-rapid-acting recombinant human insulin in a platform presentation at the 3rd International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland, on Friday, February 12, 2010, at 1pm central European time.

The presentation, entitled "Clinical Findings for Patients Treated with VIAject®, An Ultra-Rapid Acting Formulation of Recombinant Human Insulin," will review and update key data from the VIAject® clinical development program. Dr. Steiner's presentation will be available on the company's website, http://www.Biodel.com, after the presentation.

Source
Biodel Inc.

Additional
References
Citations

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.

There are no references listed for this article.

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Biodel, Inc.. "Biodel To Present Results From VIAject(R) Phase 3 Studies At Advanced Technologies And Treatments For Diabetes Conference In Basel." Medical News Today. MediLexicon, Intl., 12 Feb. 2010. Web.
6 Feb. 2012. <http://www.medicalnewstoday.com/releases/179065.php>

APA

Biodel, Inc.. (2010, February 12). "Biodel To Present Results From VIAject(R) Phase 3 Studies At Advanced Technologies And Treatments For Diabetes Conference In Basel." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/179065.php.

Please note: If no author information is provided, the source is cited instead.

Rate this article:
(Hover over the stars then click to rate)

Patient / Public:

Health Professional:

Add Your Opinion

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Follow Our Diabetes News On Twitter

Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.

Conditions Information

View list of all 'What Is...' articles »

Your Name:*
E-mail Address:*
Title For Opinion:*
Opinion:*

This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*